Literature DB >> 27866022

Novel approaches toward the generation of bioscaffolds as a potential therapy in cardiovascular tissue engineering.

Fahimeh Shahabipour1, Maciej Banach2, Thomas P Johnston3, Matteo Pirro4, Amirhossein Sahebkar5.   

Abstract

Cardiovascular disease associated with myocardial infarction (MI) is among the leading causes of mortality worldwide, in part, due to the limited regenerative capacity of tissues. Although various approaches have been employed to generate bioartificial myocardial tissues, including surgical reconstruction and the use of biosynthetic or biological cell-free grafts, many challenges still remain. Natural biomaterials based on decellularization have made significant inroads into the development of favorable biomatrices for myocardial tissue regeneration. This process occurs with the concept of removing whole cellular contents, while preserving the extracellular matrix components and all the necessary features of native tissues. Furthermore, acellular-derived matrices serve to stimulate proliferation and recruitment of endothelial cells by providing proliferation signals to cells. This review highlights a novel approach to generate natural three dimensional myocardial scaffolds for clinical applications.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bioscaffold; Cardiovascular disease; Decellularized matrix; Myocardial infarction; Tissue engineering

Mesh:

Substances:

Year:  2016        PMID: 27866022     DOI: 10.1016/j.ijcard.2016.11.210

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  In Vivo Assessment of Decellularized Porcine Myocardial Slice as an Acellular Cardiac Patch.

Authors:  Mickey Shah; Pawan Kc; Ge Zhang
Journal:  ACS Appl Mater Interfaces       Date:  2019-06-28       Impact factor: 9.229

2.  [Biocompatibility and effect on bone formation of a native acellular porcine pericardium: Results of in vitro and in vivo].

Authors:  P Y You; Y H Liu; X Z Wang; S W Wang; L Tang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-18

Review 3.  Application of decellularized bone matrix as a bioscaffold in bone tissue engineering.

Authors:  Halimeh Amirazad; Mehdi Dadashpour; Nosratollah Zarghami
Journal:  J Biol Eng       Date:  2022-01-05       Impact factor: 4.355

Review 4.  Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction.

Authors:  Vineeta Sharma; Sanat Kumar Dash; Kavitha Govarthanan; Rekha Gahtori; Nidhi Negi; Mahmood Barani; Richa Tomar; Sudip Chakraborty; Santosh Mathapati; Dillip Kumar Bishi; Poonam Negi; Kamal Dua; Sachin Kumar Singh; Rohit Gundamaraju; Abhijit Dey; Janne Ruokolainen; Vijay Kumar Thakur; Kavindra Kumar Kesari; Niraj Kumar Jha; Piyush Kumar Gupta; Shreesh Ojha
Journal:  Cells       Date:  2021-09-25       Impact factor: 6.600

Review 5.  Therapeutic Acellular Scaffolds for Limiting Left Ventricular Remodelling-Current Status and Future Directions.

Authors:  Sadia Perveen; Daniela Rossin; Emanuela Vitale; Rachele Rosso; Roberto Vanni; Caterina Cristallini; Raffaella Rastaldo; Claudia Giachino
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

6.  Crosslinked Decellularized Porcine Pericardium as a Substrate for Conjunctival Reconstruction.

Authors:  Fangyuan Chen; Jingyue Deng; Lishi Luo; Ying Zhu; Yuying Dong; Yuanting Yang; Rijia Zhang; Jian Chen; Qing Zhou
Journal:  Stem Cells Int       Date:  2022-03-15       Impact factor: 5.443

7.  Development and characterization of bladder acellular matrix cross-linked by dialdehyde carboxymethyl cellulose for bladder tissue engineering.

Authors:  Xu Peng; Pengfei Yue; Xiong Zhou; Li Li; Shuangshuang Li; Xixun Yu
Journal:  RSC Adv       Date:  2019-12-18       Impact factor: 3.361

8.  Preparation and investigation of novel SrCl2/DCMC-modified (via DOPA) decellularized arteries with excellent physicochemical properties and cytocompatibility for vascular scaffolds.

Authors:  Hao Qi; Can Cheng; Xu Wang; Xixiun Yu
Journal:  RSC Adv       Date:  2018-08-24       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.